Cargando…

The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review

Mitragynine, is a naturally occurring indole alkaloid that can be isolated from the leaves of a psychoactive medicinal plant. Mitragyna speciosa, also known as kratom, is found to possess promising analgesic effects on mediating the opioid receptors such as µ (MOR), δ (DOR), and κ (KOR). This alkalo...

Descripción completa

Detalles Bibliográficos
Autores principales: Karunakaran, Thiruventhan, Ngew, Kok Zhuo, Zailan, Ahmad Alif Danial, Mian Jong, Vivien Yi, Abu Bakar, Mohamad Hafizi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907881/
https://www.ncbi.nlm.nih.gov/pubmed/35281925
http://dx.doi.org/10.3389/fphar.2022.805986
_version_ 1784665751720820736
author Karunakaran, Thiruventhan
Ngew, Kok Zhuo
Zailan, Ahmad Alif Danial
Mian Jong, Vivien Yi
Abu Bakar, Mohamad Hafizi
author_facet Karunakaran, Thiruventhan
Ngew, Kok Zhuo
Zailan, Ahmad Alif Danial
Mian Jong, Vivien Yi
Abu Bakar, Mohamad Hafizi
author_sort Karunakaran, Thiruventhan
collection PubMed
description Mitragynine, is a naturally occurring indole alkaloid that can be isolated from the leaves of a psychoactive medicinal plant. Mitragyna speciosa, also known as kratom, is found to possess promising analgesic effects on mediating the opioid receptors such as µ (MOR), δ (DOR), and κ (KOR). This alkaloid has therapeutic potential for pain management as it has limited adverse effect compared to a classical opioid, morphine. Mitragynine is frequently regarded to behave like an opioid but possesses milder withdrawal symptoms. The use of this alkaloid as the source of an analgesic candidate has been proven through comprehensive preclinical and clinical studies. The present data have shown that mitragynine is able to bind to opioid receptors, particularly MOR, to exhibit the analgesic effect. Moreover, the chemical and pharmacological aspects of mitragynine and its diastereomers, speciogynine, speciociliatine, and mitraciliatine, are discussed. It is interesting to know how the difference in stereochemical configuration could lead to the difference in the bioactivity of the respective compounds. Hence, in this review, the updated pharmacological and toxicological properties of mitragynine and its diastereomers are discussed to render a comprehensive understanding of the pharmacological properties of mitragynine and its diastereomers based on their structure–activity relationship study.
format Online
Article
Text
id pubmed-8907881
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89078812022-03-11 The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review Karunakaran, Thiruventhan Ngew, Kok Zhuo Zailan, Ahmad Alif Danial Mian Jong, Vivien Yi Abu Bakar, Mohamad Hafizi Front Pharmacol Pharmacology Mitragynine, is a naturally occurring indole alkaloid that can be isolated from the leaves of a psychoactive medicinal plant. Mitragyna speciosa, also known as kratom, is found to possess promising analgesic effects on mediating the opioid receptors such as µ (MOR), δ (DOR), and κ (KOR). This alkaloid has therapeutic potential for pain management as it has limited adverse effect compared to a classical opioid, morphine. Mitragynine is frequently regarded to behave like an opioid but possesses milder withdrawal symptoms. The use of this alkaloid as the source of an analgesic candidate has been proven through comprehensive preclinical and clinical studies. The present data have shown that mitragynine is able to bind to opioid receptors, particularly MOR, to exhibit the analgesic effect. Moreover, the chemical and pharmacological aspects of mitragynine and its diastereomers, speciogynine, speciociliatine, and mitraciliatine, are discussed. It is interesting to know how the difference in stereochemical configuration could lead to the difference in the bioactivity of the respective compounds. Hence, in this review, the updated pharmacological and toxicological properties of mitragynine and its diastereomers are discussed to render a comprehensive understanding of the pharmacological properties of mitragynine and its diastereomers based on their structure–activity relationship study. Frontiers Media S.A. 2022-02-24 /pmc/articles/PMC8907881/ /pubmed/35281925 http://dx.doi.org/10.3389/fphar.2022.805986 Text en Copyright © 2022 Karunakaran, Ngew, Zailan, Mian Jong and Abu Bakar. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Karunakaran, Thiruventhan
Ngew, Kok Zhuo
Zailan, Ahmad Alif Danial
Mian Jong, Vivien Yi
Abu Bakar, Mohamad Hafizi
The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review
title The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review
title_full The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review
title_fullStr The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review
title_full_unstemmed The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review
title_short The Chemical and Pharmacological Properties of Mitragynine and Its Diastereomers: An Insight Review
title_sort chemical and pharmacological properties of mitragynine and its diastereomers: an insight review
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907881/
https://www.ncbi.nlm.nih.gov/pubmed/35281925
http://dx.doi.org/10.3389/fphar.2022.805986
work_keys_str_mv AT karunakaranthiruventhan thechemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview
AT ngewkokzhuo thechemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview
AT zailanahmadalifdanial thechemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview
AT mianjongvivienyi thechemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview
AT abubakarmohamadhafizi thechemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview
AT karunakaranthiruventhan chemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview
AT ngewkokzhuo chemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview
AT zailanahmadalifdanial chemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview
AT mianjongvivienyi chemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview
AT abubakarmohamadhafizi chemicalandpharmacologicalpropertiesofmitragynineanditsdiastereomersaninsightreview